Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Dev Cell ; 1(1): 13-25, 2001 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-11703920

RESUMO

Recent studies have yielded a number of important insights into the mechanisms of hair follicle development and cycling and have highlighted the particularly important roles played by stem cells and Wnt signaling pathways.


Assuntos
Folículo Piloso/citologia , Folículo Piloso/crescimento & desenvolvimento , Transdução de Sinais/fisiologia , Animais , Divisão Celular/fisiologia , Humanos , Células-Tronco/citologia
2.
Genes Dev ; 15(13): 1688-705, 2001 Jul 01.
Artigo em Inglês | MEDLINE | ID: mdl-11445543

RESUMO

In skin, multipotent stem cells generate the keratinocytes of the epidermis, sebaceous gland, and hair follicles. In this paper, we show that Tcf3 and Lef1 control these differentiation lineages. In contrast to Lef1, which requires Wnt signaling and stabilized beta-catenin to express the hair-specific keratin genes and control hair differentiation, Tcf3 can act independently of its beta-catenin interacting domain to suppress features of epidermal terminal differentiation, in which Tcf3 is normally shut off, and promote features of the follicle outer root sheath (ORS) and multipotent stem cells (bulge), the compartments which naturally express Tcf3. These aspects of Tcf3's action are dependent on its DNA binding and Groucho repressor-binding domains. In the absence of its beta-catenin interacting domain, Lef1's behavior (Delta NLef1) seems to be markedly distinct from that of Delta NTcf3. Delta NLef1 does not suppress epidermal differentiation and promote ORS/bulge differentiation, but rather suppresses hair differentiation and gives rise to sebocyte differentiation. Taken together, these findings provide powerful evidence that the status of Tcf3/Lef complexes has a key role in controlling cell fate lineages in multipotent skin stem cells.


Assuntos
Proteínas de Ligação a DNA/metabolismo , Proteínas HMGB , Pele/citologia , Células-Tronco/citologia , Transativadores , Fatores de Transcrição/metabolismo , Animais , Diferenciação Celular , Linhagem da Célula , Núcleo Celular/metabolismo , Células Cultivadas , Proteínas do Citoesqueleto/metabolismo , Proteínas de Ligação a DNA/genética , Células Epidérmicas , Epiderme/metabolismo , Humanos , Queratinócitos/citologia , Fator 1 de Ligação ao Facilitador Linfoide , Camundongos , Camundongos Transgênicos , Proteínas Recombinantes de Fusão/genética , Proteínas Recombinantes de Fusão/metabolismo , Fatores de Transcrição TCF , Proteína 1 Semelhante ao Fator 7 de Transcrição , Fatores de Transcrição/genética , beta Catenina
3.
Mol Cell Biol ; 19(11): 7801-15, 1999 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-10523669

RESUMO

To understand the role of POL30 in mutation suppression, 11 Saccharomyces cerevisiae pol30 mutator mutants were characterized. These mutants were grouped based on their mutagenic defects. Many pol30 mutants harbor multiple mutagenic defects and were placed in more than one group. Group A mutations (pol30-52, -104, -108, and -126) caused defects in mismatch repair (MMR). These mutants exhibited mutation rates and spectra reminiscent of MMR-defective mutants and were defective in an in vivo MMR assay. The mutation rates of group A mutants were enhanced by a msh2 or a msh6 mutation, indicating that MMR deficiency is not the only mutagenic defect present. Group B mutants (pol30-45, -103, -105, -126, and -114) exhibited increased accumulation of either deletions alone or a combination of deletions and duplications (4 to 60 bp). All deletion and duplication breakpoints were flanked by 3 to 7 bp of imperfect direct repeats. Genetic analysis of one representative group B mutant, pol30-126, suggested polymerase slippage as the likely mutagenic mechanism. Group C mutants (pol30-100, -103, -105, -108, and -114) accumulated base substitutions and exhibited synergistic increases in mutation rate when combined with msh6 mutations, suggesting increased DNA polymerase misincorporation as a mutagenic defect. The synthetic lethality between a group A mutant, pol30-104, and rad52 was almost completely suppressed by the inactivation of MSH2. Moreover, pol30-104 caused a hyperrecombination phenotype that was partially suppressed by a msh2 mutation. These results suggest that pol30-104 strains accumulate DNA breaks in a MSH2-dependent manner.


Assuntos
Sistemas de Transporte de Aminoácidos , Pareamento Incorreto de Bases , Reparo do DNA , Replicação do DNA , Proteínas Fúngicas/genética , Mutagênese , Antígeno Nuclear de Célula em Proliferação/genética , Saccharomyces cerevisiae/genética , Sequência de Bases , DNA Polimerase Dirigida por DNA/metabolismo , Mutação da Fase de Leitura , Proteínas de Membrana Transportadoras/genética , Dados de Sequência Molecular , Mutagênese Insercional , Mutação Puntual , Deleção de Sequência
4.
Genetics ; 153(2): 595-605, 1999 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-10511542

RESUMO

To examine the role of the RAD52 recombinational repair pathway in compensating for DNA replication defects in Saccharomyces cerevisiae, we performed a genetic screen to identify mutants that require Rad52p for viability. We isolated 10 mec1 mutations that display synthetic lethality with rad52. These mutations (designated mec1-srf for synthetic lethality with rad-fifty-two) simultaneously cause two types of phenotypes: defects in the checkpoint function of Mec1p and defects in the essential function of Mec1p. Velocity sedimentation in alkaline sucrose gradients revealed that mec1-srf mutants accumulate small single-stranded DNA synthesis intermediates, suggesting that Mec1p is required for the normal progression of DNA synthesis. sml1 suppressor mutations suppress both the accumulation of DNA synthesis intermediates and the requirement for Rad52p in mec1-srf mutants, but they do not suppress the checkpoint defect in mec1-srf mutants. Thus, it appears to be the DNA replication defects in mec1-srf mutants that cause the requirement for Rad52p. By using hydroxyurea to introduce similar DNA replication defects, we found that single-stranded DNA breaks frequently lead to double-stranded DNA breaks that are not rapidly repaired in rad52 mutants. Taken together, these data suggest that the RAD52 recombinational repair pathway is required to prevent or repair double-stranded DNA breaks caused by defective DNA replication in mec1-srf mutants.


Assuntos
Reparo do DNA/genética , Replicação do DNA/genética , Proteínas Fúngicas/genética , Recombinação Genética , Proteínas de Saccharomyces cerevisiae , Saccharomyces cerevisiae/genética , DNA Fúngico/biossíntese , DNA Fúngico/genética , DNA de Cadeia Simples/biossíntese , DNA de Cadeia Simples/genética , Proteínas de Ligação a DNA/genética , Proteínas Fúngicas/metabolismo , Genótipo , Hidroxiureia/farmacologia , Peptídeos e Proteínas de Sinalização Intracelular , Mutagênese , Proteínas Serina-Treonina Quinases , Proteína Rad52 de Recombinação e Reparo de DNA , Saccharomyces cerevisiae/efeitos dos fármacos
5.
Genetics ; 148(2): 611-24, 1998 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-9504910

RESUMO

To identify in vivo pathways that compensate for impaired proliferating cell nuclear antigen (PCNA or Pol30p in yeast) activity, we performed a synthetic lethal screen with the yeast pol30-104 mutation. We identified nine mutations that display synthetic lethality with pol30-104; three mutations affected the structural gene for the large subunit of replication factor C (rfc1), which loads PCNA onto DNA, and six mutations affected three members of the RAD52 epistasis group for DNA recombinational repair (rad50, rad52 and rad57). We also found that pol30-104 displayed synthetic lethality with mutations in other members of the RAD52 epistasis group (rad51 and rad54), but not with mutations in members of the RAD3 nor the RAD6 epistasis group. Analysis of nine different pol30 mutations shows that the requirement for the RAD52 pathway is correlated with a DNA replication defect but not with the relative DNA repair defect caused by pol30 mutations. In addition, mutants that require RAD52 for viability (pol30-100, pol30-104, rfc1-1 and rth1delta) accumulate small single-stranded DNA fragments during DNA replication in vivo. Taken together, these data suggest that the RAD52 pathway is required when there are defects in the maturation of Okazaki fragments.


Assuntos
Reparo do DNA/genética , Proteínas de Ligação a DNA/genética , Genes pol/genética , Antígeno Nuclear de Célula em Proliferação/fisiologia , Recombinação Genética/genética , Saccharomyces cerevisiae/genética , Divisão Celular/genética , Sobrevivência Celular/genética , Centrifugação com Gradiente de Concentração , DNA/genética , Replicação do DNA/genética , Epistasia Genética , Citometria de Fluxo , Modelos Moleculares , Mutagênese/genética , Mutação , Antígeno Nuclear de Célula em Proliferação/genética , Proteína Rad52 de Recombinação e Reparo de DNA , Proteínas de Saccharomyces cerevisiae , Temperatura
7.
Arch Biochem Biophys ; 308(1): 133-6, 1994 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-8311445

RESUMO

Neprilysin is a peptidase which has a specificity directed toward cleavage on the amino side of hydrophobic residues. In addition an active site arginine on the enzyme can interact with the C-terminal carboxylate of a substrate. The importance of the position of the hydrophobic residue relative to the C-terminus of the substrate has been investigated using a series of peptides containing one or two cleavage sites. With a hexapeptide series succ-(GLy)x-Phe-(Gly)y-OH, where x = 1 to 5 and y = 5 to 1 respectively, a approximately 25-fold increase in the specificity constant kcat/Km was observed when Phe was adjacent to the C-terminal Gly residue. With peptide-free acids containing two cleavable bonds (X and Y) of the type succ-Gly-X-Gly-Y-Gly-OH, cleavage was observed at the Y residue. However, when the two cleavable bonds were adjacent, succ-Gly-Gly-X-Y-Gly-OH, cleavage of a tripeptide was observed even when the residue in position X was one cleaved poorly when presented as the sole cleavage site. These results demonstrate a preference by the enzyme for the placement of a hydrophobic residue in the P'2 position.


Assuntos
Neprilisina/metabolismo , Oligopeptídeos/metabolismo , Sequência de Aminoácidos , Animais , Bombesina/química , Bombesina/metabolismo , Glicina , Rim/enzimologia , Dados de Sequência Molecular , Neprilisina/isolamento & purificação , Oligopeptídeos/síntese química , Fenilalanina , Ratos , Espectrometria de Fluorescência , Especificidade por Substrato
8.
FEBS Lett ; 335(1): 65-8, 1993 Nov 29.
Artigo em Inglês | MEDLINE | ID: mdl-7694875

RESUMO

Regulation of cholecystokinin (CCK) expression was studied in the human neuroepithelioma cell line SK-N-MCIXC. The cells were treated with the phosphodiesterase inhibitor isobutyl-methylxanthine and the tumor promoting phorbol ester, phorbol-12-myristate 13-acetate; activators of the cyclic AMP (cAMP) and protein kinase C (PKC) second messenger pathways, respectively. Levels of CCK mRNA were determined after 6, 12 and 24 hour drug treatments, with Northern blot analysis using human CCK cDNA hybridization probes. Activation of both cAMP and PKC second messenger pathways increased CCK mRNA levels in SK-N-MCIXC cells. These results indicate that the levels of CCK mRNA in SK-N-MCIXC cells are regulated by cAMP and PKC dependent mechanisms.


Assuntos
Colecistocinina/genética , Regulação da Expressão Gênica , Tumores Neuroectodérmicos Primitivos Periféricos/metabolismo , RNA Mensageiro/metabolismo , Sistemas do Segundo Mensageiro , 1-Metil-3-Isobutilxantina/farmacologia , 8-Bromo Monofosfato de Adenosina Cíclica/farmacologia , Linhagem Celular , AMP Cíclico/metabolismo , Dimetil Sulfóxido/farmacologia , Humanos , Cinética , Proteína Quinase C/antagonistas & inibidores , Proteína Quinase C/metabolismo , Acetato de Tetradecanoilforbol/farmacologia
9.
Life Sci ; 51(26): 2097-106, 1992.
Artigo em Inglês | MEDLINE | ID: mdl-1361957

RESUMO

A specific enzyme assay for aminopeptidase M (APM) activity on rat brain membranes has been developed through selective use of enzyme inhibitors. Amastatin was the most potent inhibitor (amastatin > actinonin > MDL73347 > bestatin) for purified porcine kidney APM, giving 98% inhibition at a 6 microM concentration, while actinonin, yielded only 57% inhibition at this concentration. Puromycin (10 microM) was used to inhibit puromycin-sensitive aminopeptidase activity in the rat brain membrane preparation. Puromycin (10 microM) had only a slight effect on the Km of porcine kidney APM, and had negligible effect on APM velocity at the high substrate concentration (2 mM) used in the APM assay. The assay produced a linear accumulation of product for increasing amount of rat brain membranes used, and for increasing incubation time. The Km of APM on rat brain membranes for L-Leucine-p-nitroanilide (0.383 mM) was similar to the Km of purified porcine kidney APM (0.558 mM). APM-activity, involved in the metabolism of several biologically important neuropeptides in different brain regions, can be specifically measured with this enzyme assay.


Assuntos
Aminopeptidases/análise , Córtex Cerebral/enzimologia , Aminopeptidases/antagonistas & inibidores , Animais , Antígenos CD13 , Inibidores Enzimáticos/farmacologia , Rim/enzimologia , Cinética , Masculino , Ratos , Ratos Sprague-Dawley
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...